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Human Campylobacter jejuni infections are progressively rising worldwide. Information
about the molecular mechanisms underlying campylobacteriosis, however, are limited. In
the present study we investigated whether cytokines such as IL-23, IL-22 and IL-18, which
share pivotal functions in host immunity, were involved in mediating intestinal and systemic
immunopathological responses upon C. jejuni infection.
Methodology/Principal Findings
To assure stable infection, gnotobiotic (i.e. secondary abiotic) IL-23p19-/-, IL-22-/- and IL-
18-/- mice were generated by broad-spectrum antibiotic treatment. Following peroral C.
jejuni strain 81–176 infection, mice of all genotypes harbored comparably high pathogenic
loads in their intestines. As compared to wildtype controls, however, IL-18-/- mice displayed
less distinct C. jejuni induced sequelae as indicated by less pronounced large intestinal
shrinkage and lower numbers of apoptotic cells in the colonic epithelial layer at day 8 postin-
fection (p.i.). Furthermore, lower colonic numbers of adaptive immune cells including regu-
latory T cells and B lymphocytes were accompanied by less distinct secretion of pro-
inflammatory cytokines such as TNF and IFN-γ and lower IL-17A mRNA expression levels
in colonic ex vivo biopsies of infected IL-18-/- as compared to wildtype mice. Upon C. jejuni
infection, colonic IL-23p19 expression was up-regulated in IL-18-/- mice only, whereas IL-22
mRNA levels were lower in uninfected and infected IL-23p19-/- as well as infected IL-18-/- as
compared to respective wildtype control mice. Remarkably, not only intestinal, but also sys-
temic infection-induced immune responses were less pronounced in IL-18-/- mice as indi-
cated by lower TNF, IFN-γ and IL-6 serum levels as compared to wildtype mice.
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Conclusion/Significance
We here show for the first time that IL-18 is essentially involved in mediating C. jejuni infec-
tion in the gnotobiotic mouse model. Future studies need to further unravel the underlying
regulatory mechanisms orchestrating pathogen-host interaction.
Introduction
During the past decade, human infections with the zoonotic pathogen Campylobacter jejuni
have progressively risen in developed as well as developing countries [1–3]. Whereas C. jejuni
is considered a commensal strain in the intestinal tract of many wild and domestic animal spe-
cies, it can cause human disease of considerable variability following transmission via the food
chain [4–6]. Whereas infected individuals may be asymptomatic or exhibit rather mild symp-
toms including watery diarrhea, other patients suffer from acute ulcerative enterocolitis with
inflammatory bloody diarrhea and abdominal cramps lasting for up to a few days or even
weeks [7]. In the vast majority of cases, the course of disease is self-limited. On rare occasions,
however, post-infectious sequelae such as reactive arthritis or neurological complications
including Guillain-Barré and Miller-Fisher syndromes may arise with a latency of several
weeks to months postinfection (p.i.) [7, 8]. Intestinal immunopathology in human campylo-
bacteriosis is characterized by histological changes including apoptosis, crypt abscesses, ulcera-
tions and pronounced influx of distinct pro-inflammatory immune cell subsets including
lymphocytes and neutrophils into the intestinal mucosa and lamina propria [9, 10]. Despite its
global importance, our understanding of the molecular mechanisms underlying campylobac-
teriosis, however, is limited due to fundamental shortcomings in experimental infection model
systems. Chicken, primates, newborn piglets, weanling ferrets, and gnotobiotic canine pups
have been applied for studying pathogen-host interactions with limited success only, whereas
mice are prevented from stable C. jejuni colonization due to the physiological colonization
resistance exerted by their conventional intestinal microbiota [3, 7]. We have recently shown
that colonization resistance can be abrogated by depletion of the commensal intestinal micro-
biota following broad-spectrum antibiotic treatment [11]. In turn, generated gnotobiotic (i.e.
secondary abiotic) mice could be stably colonized by the pathogen at high loads upon peroral
challenge and displayed distinct pathogen-induced pro-inflammatory immune and apoptotic
responses in their intestinal tract, hence mimicking key features of campylobacteriosis in men
[11]. Thus, the gnotobiotic mice infection model has been proven suitable to further dissect C.
jejuni-host interactions.
Our previous studies revealed that IL-23p19, IL-22 and IL-18, which share pivotal functions
in host immunity [12–15], were upregulated in the large intestines of both conventional infant
[16] and secondary abiotic adult mice following peroral C. jejuni infection [17]. Recently, IL-23
was highlighted as a master regulator of mucosal immune responses upon intestinal infection
and inflammation [18], whereas IL-22 belonging to the IL-10 family exerts potent antimicro-
bial and tissue-protective, but also pro-inflammatory properties [19, 20]. Particularly in the
intestinal tract, IL-22 acts in a dichotomous fashion depending on the respective compartment.
In the large intestines, for instance, IL-22 exerts its anti-inflammatory properties [20]. Our
group showed recently that in the small intestinal tract, however, IL-22 acts as a pro-inflamma-
tory cytokine, given that acute Toxoplasma gondii induced ileitis was caused by IL-23p19
dependent IL-22 induction [21–23].
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IL-18 was initially identified as a cytokine promoting T helper cell (Th) -1 development and
IFN-γ production [14]. For generating the active form of IL-18, inflammasome activation and
caspase-mediated enzymatic cleavage is required [24]. Our recent studies revealed that IL-18
mRNA expression in intestinal epithelial cells is induced by IL-22 following T. gondii infection,
whereas, IL-18 amplified IL-22 production from innate lymphoid cells (ILCs) and Th-1 medi-
ated intestinal inflammation [23]. So far, however, it is unclear whether such a mutual regula-
tion between IL-22 and IL-18 also holds true for C. jejuni infection. Overall, information about
the distinct roles of cytokines belonging to the IL-23 / IL-22 / IL-18 axis in C. jejuni infection
are scarce.
In the present study we hence aimed to elucidate the impact of the IL-23 / IL-22 / IL-18 axis
in C. jejuni-host interaction and investigated macroscopic and microscopic pathogen-induced
sequelae as well as local and systemic pro-inflammatory immune responses in perorally C.
jejuni infected gnotobiotic adult mice that were gene-deficient for either IL-23p19, IL-22 or IL-
18. For the first time we were able to show that IL-18 is essentially involved in mediating intes-
tinal and systemic immune responses upon murine C. jejuni infection.
Methods
Ethics statement
All animal experiments were conducted according to the European Guidelines for animal wel-
fare (2010/63/EU) with approval of the commission for animal experiments (ethical commit-
tee) headed by the “Landesamt für Gesundheit und Soziales” (LaGeSo, Berlin, registration
number G0135/10). Animal welfare was monitored twice daily by assessment of body weights
and clinical conditions including occurrence of blood in murine fecal samples. Suffering of
mice was ameliorated whenever applicable according to the legacy of the animal ethical com-
mittee. At day of necropsy (i.e. day 8 p.i.) mice were anaethesized by isofluran (Abbott, Greifs-
wald, Germany) inhalation.
Mice and C. jejuni infection
Female IL-23p19-/-, IL-22-/- and IL-18-/- mice (all in C57BL/6j background) as well as age- and
sex-matched C57BL/6j wildtype (WT) control mice were bred and maintained within the same
specific pathogen free (SPF) unit in the Forschungseinrichtungen für Experimentelle Medizin
(FEM), Charité—University Medicine Berlin. In order to confirm absence of IL-23p19, IL-22
or IL-18 gene expression, genomic DNA was isolated and disruption of either gene confirmed
by polymerase chain reaction (PCR) [21]. Gnotobiotic (i.e. secondary abiotic) mice with a vir-
tually depleted gastrointestinal microbiota were generated by broad-spectrum antibiotic treat-
ment as described earlier [25]. In brief, mice were transferred to sterile cages and treated by
adding ampicillin/sulbactam (1 g/L; Pfizer, Berlin, Germany), vancomycin (500 mg/L; Hexal,
Holzkirchen, Germany), ciprofloxacin (200 mg/L; Hexal), imipenem (250 mg/L; Fresenius
Kabi, Graz, Austria), and metronidazole (1 g/L; Braun, Melsungen, Germany) to the drinking
water ad libitum starting eight weeks of age and continued for 10 weeks before the infection
experiment. Three days before infection, the antibiotic cocktail was replaced by sterile tap
water (ad libitum). On two consecutive days (day 0 and day 1) mice were perorally infected
with 109 colony forming units (CFU) of viable C. jejuni strain 81–176 in a volume of 0.3 mL
phosphate buffered saline (PBS) by gavage as described earlier [11]. Mice were continuously
kept in a sterile environment (autoclaved food and tap water) and handeled under strict aseptic
conditions. Uninfected gnotobiotic WT, IL-23p19-/-, IL-22-/- and IL-18-/- mice served as
respective negative (uninfected) control groups. A minimum of three mice per group were
included into the experiments.
IL-18 in MurineC. jejuni Infection
PLOS ONE | DOI:10.1371/journal.pone.0158020 June 20, 2016 3 / 18
Sampling procedures
Mice were sacrificed at day 8 postinfection (p.i.) by isofluran treatment (Abbott, Greifswald,
Germany). Cardiac blood and tissue samples from colon, mesenteric lymph nodes (MLN),
spleen, liver and kidney were asserved under sterile conditions. Absolute large intestinal
lengths were determined by measuring the distance from the ascending colon leaving the cae-
cum to the rectum by a ruler. Colonic ex vivo biopsies were collected in parallel for immunohis-
tochemical, microbiological and immunological analyses. Immunohistopathological changes
were assessed in sections (5 μm) of colonic samples that were immediately fixed in 5% formalin
and embedded in paraffin.
Immunohistochemistry
In situ immunohistochemical analysis of colonic paraffin sections was performed as described
previously [17, 26]. Primary antibodies against cleaved caspase-3 (Asp175, Cell Signaling, Bev-
erly, MA, USA, 1:200), Ki67 (TEC3, Dako, Denmark, 1:100), CD3 (#N1580, Dako, 1:10),
FOXP3 (FJK-16s, eBioscience, 1:100), B220 (eBioscience, 1:200), and F4/80 (# 14–4801, clone
BM8, eBioscience, San Diego, CA, USA, 1:50) were used. For each animal, the average number
of positively stained cells within at least six high power fields (HPF, 0.287 mm2, 400 x magnifi-
cation) were determined microscopically by a double-blinded investigator.
Quantitative analysis of bacterial colonization and translocation
Viable C. jejuni were detected in feces over time p.i. or in luminal colonic samples at time of
necropsy (i.e. day 8 p.i.), dissolved in sterile PBS and serial dilutions cultured on Karmali- and
Columbia-Agar supplemented with 5% sheep blood (Oxoid) for two days at 37°C under micro-
aerobic conditions using CampyGen gas packs (Oxoid). To quantify bacterial translocation, ex
vivo biopsies derived from MLNs, spleen, liver and kidney were homogenized in 1 mL sterile
PBS, whereas cardiac blood (100 μL) was directly streaked onto Karmali-Agar and Colum-
bia-Agar supplemented with 5% sheep blood and cultivated accordingly. The respective
weights of fecal or tissue samples were determined by the difference of the sample weights
before and after asservation. The detection limit of viable pathogens was100 colony forming
units (CFU) per gram (g) as assessed by direct plating.
Cytokine detection in supernatants of colonic ex vivo biopsies
Colonic tissue samples were cut longitudinally and washed in PBS. Strips of approximately 1
cm2 intestinal tissue were placed in 24-flat-bottom well culture plates (Nunc, Wiesbaden, Ger-
many) containing 500 μL serum-free RPMI 1640 medium (Gibco, life technologies, Paisley,
UK) supplemented with penicillin (100 U/mL) and streptomycin (100 μg/mL; PAA Laborato-
ries). After 18 h at 37°C, culture supernatants or serum samples were tested for TNF, IFN-γ,
and IL-6 by the Mouse Inflammation Cytometric Bead Assay (CBA; BD Biosciences) on a BD
FACSCanto II flow cytometer (BD Biosciences).
Real-time PCR
RNA was isolated from snap frozen colonic ex vivo biopsies, reverse transcribed and analyzed
as described previously [21]. In brief, murine IL-23p19, IL-22, IL-18, IL-17A and IL-1βmRNA
expressions were detected and analyzed using Light Cycler Data Analysis Software (Roche).
The mRNA of the housekeeping gene for hypoxanthine-phosphoribosyltransferase (HPRT)
was used as reference, the mRNA expression levels of the individual genes were normalized to
the lowest measured value and expressed as fold expression (Arbitrary Units).
IL-18 in MurineC. jejuni Infection
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Statistical analysis
Medians, means and levels of significance were determined using Mann-Whitney U test (Graph-
Pad Prism v6.05, La Jolla, CA, USA) as indicated. Two-sided probability (P) values 0.05 were
considered significant. Experiments were reproduced at least twice.
Results
Colonization properties of C. jejuni in gnotobiotic mice lacking IL-23p19,
IL-22 or IL18
In the present study we dissected the role of cytokines belonging to the IL-23 / IL-22 / IL-18
axis in murine campylobacteriosis. To address this, gnotobiotic IL-23p19-/-, IL-22-/-, IL-18-/-
and corresponding WT control mice with a virtually depleted commensal intestinal microbiota
were generated by broad-spectrum antibiotic treatment [11, 25–29]. Upon peroral infection
with 109 CFU of C. jejuni strain 81–176 on two consecutive days (day 0 and day 1), mice of all
genotypes were stably infected with comparably high pathogenic loads of approximately 109
CFU per g luminal colonic sample at day 8 p.i. (Fig 1A). At the same time point, viable C. jejuni
could also be isolated fromMLNs of gnotobiotic mice, irrespective of their genotype, with
median loads of 104 CFU per g organ homogenate (Fig 1B).
Macroscopic and microscopic sequelae of C. jejuni infection in
gnotobiotic mice lacking IL-23p19, IL-22 or IL18
We next surveyed the effect of IL-23, IL-22 and IL-18 in mediating inflammatory responses
during murine C. jejuni infection. Overall, mice of all genotypes were rather uncompromized
from their clinical aspect, given that only in single cases (i.e. 9.5%, 5.0%, 8.3% and 10.5%,
respectively) occult blood could be detected microscopically in fecal samples derived fromWT,
IL-23-/-, IL-22-/- and IL-18-/- mice at day 8 p.i. (S1 Fig). As early as 24 hours following the first
of two consecutive C. jejuni infections, however, more than 20% of IL-18-/- mice as compared
to 5% of IL-23p19-/-, but none of IL-22-/- and WT mice displayed fecal blood (S1A Fig).
Whereas later during the course of infection IL-18-/- mice had recovered and were free of blood
in their feces, almost half of WT mice were fecal blood-positive at day 5 p.i. (S1B Fig).
Since intestinal inflammation results in significant shortening of the intestinal tract [25, 27],
we next measured colonic lengths at days of necropsy. In fact, shorter colonic lengths could be
observed in WT, IL-23p19-/-, and IL-22-/-, but, interestingly, not in IL-18-/- mice at day 8 p.i. as
compared to respective uninfected control animals (Fig 2), hence pointing towards less distinct
C. jejuni induced inflammatory responses in IL-18-/- mice.
Given that apoptosis is used as an established diagnostic marker in the histopathological
evaluation and grading of intestinal disease and a hallmark of murine campylobacteriosis [27],
we next determined numbers of caspase-3+ cells within the colonic epithelial layer of infected
mice. Irrespective of their genotype, numbers of apoptotic cells increased upon C. jejuni infec-
tion, but less distinctly in IL-18-/- and IL-23p19-/- as compared to WT mice (p<0.05; Fig 3A).
We further stained colonic paraffin sections against Ki67 in order to determine proliferative
measures of the colonic epithelium counteracting apoptosis following C. jejuni infection, given
that Ki67 comprizes a nuclear protein associated with and necessary for cellular proliferation
[30]. Contrary to apoptotic cells, numbers of Ki67 cells were higher in C. jejuni infected WT
and gene-deficient as compared to respective uninfected control mice (p<0.001; Fig 3B).
Gene-deficient mice, however, displayed approximately more than 30% higher proliferating
colonic mucosal cell numbers as compared to WT controls at day 8 p.i. (p<0.001; Fig 3B).
IL-18 in MurineC. jejuni Infection
PLOS ONE | DOI:10.1371/journal.pone.0158020 June 20, 2016 5 / 18
Taken together, the better macroscopic aspects observed in C. jejuni infected IL-18-/- mice was
accompanied by less distinct histological sequelae within the large intestinal mucosa.
Immune cell responses in C. jejuni strain 81–176 infected gnotobiotic
mice lacking IL-23p19, IL-22 or IL-18
Recruitment of pro-inflammatory immune cells to sites of inflammation is a well-known hall-
mark of intestinal pathogenic infection including campylobacteriosis [11]. We therefore quan-
titatively assessed the numbers of innate and adaptive immune cells within the large intestinal
mucosa and lamina propria upon C. jejuni infection by in situ immunohistochemical staining
of colonic paraffin sections. Irrespective of the genotype of mice, numbers of colonic CD3+ T
lymphocytes, FOXP3+ regulatory T cells (Tregs), B220+ B lymphocytes, as well as of F4/80+
macrophages and monocytes increased until day 8 p.i. (p<0.001; Fig 4). In IL-22-/- mice, num-
bers of colonic T lymphocytes and Tregs were even higher when compared to infected WT
mice at day 8 p.i. (p<0.001 and p<0.01, respectively; Fig 4A and 4B), whereas C. jejuni infected
IL-18-/- mice displayed lower Treg and B lymphocyte numbers in their colon as compared to
infected WT animals (p<0.05; Fig 4B and 4C). Hence IL-18 mediates adaptive immune
responses in C. jejuni infected gnotobiotic mice.
Pro-inflammatory cytokine expression in the colon of C. jejuni strain 81–
176 infected gnotobiotic mice lacking IL-23p19, IL-22 or IL-18
We next assessed colonic pro-inflammatory cytokine secretion during murine C. jejuni infec-
tion. Eight days p.i., WT, IL-23p19-/- and IL-22-/-, but not IL-18-/- mice displayed increased
TNF concentrations in colonic ex vivo biopsies (p<0.001; Fig 5A). In addition, not only colonic
Fig 1. IntestinalC. jejuni loads in perorally infected gnotobiotic mice lacking IL-23p19, IL-22 or IL-18.Gnotobiotic wildtype (WT), IL-23p19-/-, IL-22-/-
and IL-18-/- mice were generated by broad-spectrum antibiotic treatment and perorally infected with C. jejuni strain 81–176 by gavage at day 0 and day 1.
Pathogenic loads (colony forming units (CFU) per gram) were determined in (A) colonic luminal samples and (B) homogenates of mesenteric
lymphnodes (MLN) at day 8 postinfection by culture. Numbers of analyzed mice (in parentheses), medians (black bars) and level of significance (p-value)
determined by Mann-Whitney U test are indicated. Data were pooled from four independent experiments.
doi:10.1371/journal.pone.0158020.g001
IL-18 in MurineC. jejuni Infection
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TNF, but also IFN-γ levels were lower in IL-18-/- mice as compared to WT, IL-23p19-/- and IL-
22-/- mice at day 8 p.i. (p<0.001, Fig 5A and 5B), whereas C. jejuni induced increases in colonic
IL-6 secretion were less pronounced in IL-18-/- versus IL-23p19-/- mice (p<0.05; Fig 5C). Fur-
thermore, C. jejuni infection was accompanied by up-regulated large intestinal IL-17A and IL-
1βmRNA expression (p<0.001; Fig 6). Increase in colonic IL-17A mRNA, however, was less
distinct in IL-18-/- mice (p<0.01–0.001 versus infected WT, IL-23p19-/- and IL-22-/- mice; Fig
6B), whereas IL-1β was significantly less distinctly expressed in the large intestines of IL-18-/-
as compared to IL-23p19-/- mice at day 8 p.i. (p<0.05; Fig 6B). Taken together, IL-18 mediates
C. jejuni induced pro-inflammatory cytokine responses in gnotobiotic mice.
Colonic IL-23p19, IL-22 and IL-18 mRNA levels in C. jejuni infected
gnotobiotic mice
We next assessed whether colonic IL-23p19, IL-22 and IL-18 mRNA were differentially
expressed in gnotobiotic IL-23p19-/-, IL-22-/- and IL-18-/- mice upon C. jejuni infection. As
expected, IL-23p19, IL-22 or IL-18 mRNA could not be detected in colonic ex vivo biopsies
Fig 2. Colonic lengths of perorallyC. jejuni strain 81–176 infected gnotobiotic mice lacking IL-23p19, IL-22 or IL-18. Absolute colonic lengths of
mice were determined at day of necropsy (day (d) 8 postinfection). Naive (N) mice served as uninfected controls. Numbers of analyzed animals (in
parentheses), means (black bars) and level of significance (p-value) determined by Mann-Whitney U test are indicated. Data were pooled from four
independent experiments.
doi:10.1371/journal.pone.0158020.g002
IL-18 in MurineC. jejuni Infection
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Fig 3. Apoptotic and proliferating cells in the colonic epithelium ofC. jejuni strain 81–176 infected
gnotobiotic mice lacking IL-23p19, IL-22 or IL-18. The average number of colonic (A) apoptotic cells (positive
for caspase-3, Casp3) and (B) proliferating cells (positive for Ki67) from at least six high power fields (HPF,
400x magnification) per mouse was determined microscopically in immunohistochemically stained colonic
paraffin sections at day (d) 8 (black circles) postinfection. Naive (N) mice served as uninfected controls (white
IL-18 in MurineC. jejuni Infection
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taken from respective gene-deficient mice (Fig 7). Upon C. jejuni infection, however, IL-23p19
expression was upregulated in IL-18-/- mice only and, hence, mRNA levels were higher as com-
pared to infected mice of the remaining genotypes (p<0.01; Fig 7A). Interestingly, IL-22
mRNA levels were lower in uninfected IL-23p19-/- as compared to WT and IL-18-/- mice
(p<0.05 and p<0.01, respectively; Fig 7B). Upon infection, colonic IL-22 mRNA expression
was up-regulated, but mRNA levels were lower in IL-23p19-/- and IL-18-/- than WT mice at
day 8 p.i. (p<0.01 and p<0.05, respectively; Fig 7B). Basal IL-18 mRNA levels, however,
were slightly lower in uninfected IL-23p19-/- and IL-22-/- as compared to WT mice (p<0.05;
circles). Medians (black bars), level of significance (p-value) determined by Mann-Whitney U test, and numbers
of analyzed animals (in parentheses) are indicated. Data were pooled from four independent experiments.
doi:10.1371/journal.pone.0158020.g003
Fig 4. Colonic immune cell responses inC. jejuni strain 81–176 infected gnotobiotic mice lacking IL-23p19, IL-22 or IL-18. The average number of
colonic epithelial cells positive for (A) CD3 (T Lymphocytes), (B) FOXP3 (Regulatory T Cells, Tregs), (C) B220 (B Lymphocytes), and (D) F4/80
(Macrophages / Monocytes) from at least six high power fields (HPF, 400x magnification) per animal was determined microscopically in
immunohistochemically stained colonic paraffin sections at day (d) 8 (black circles) postinfection. Naive (N) mice served as uninfected controls (white
circles). Medians (black bars), level of significance (p-value) determined by Mann-Whitney U test, and numbers of analyzed animals (in parentheses) are
indicated. Data were pooled from four independent experiments.
doi:10.1371/journal.pone.0158020.g004
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Fig 5. Pro-inflammatory cytokine secretion in colonic ex vivo biopsies derived fromC. jejuni strain
81–176 infected gnotobiotic mice lacking IL-23p19, IL-22 or IL-18. (A) TNF, (B) IFN-γ, and (C) IL-6
concentrations were determined in supernatants of colonic ex vivo biopsies derived from gnotobiotic wildtype
(WT), IL-23p19-/-, IL-22-/- and IL-18-/- mice at day (d) 8 (black circles) postinfection. Naive (N) mice served as
uninfected controls (white circles). Medians (black bars), level of significance (p-value) determined by Mann-
IL-18 in MurineC. jejuni Infection
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Fig 7C). Remarkably, C. jejuni infection did not result in increased colonic IL-18 mRNA
expression in mice of all genotypes (not significant; Fig 7C).
Pathogenic translocation and systemic pro-inflammatory responses in
C. jejuni infected gnotobiotic mice lacking IL-23p19, IL-22 or IL-18
We furthermore assessed potential systemic inflammatory responses upon C. jejuni infection.
To address this, we investigated whether viable pathogens had translocated from the intestinal
tract to extra-intestinal compartments including spleen, liver, kidney and cardiac blood upon
peroral infection. By direct plating, C. jejuni could be isolated from spleens of only single or
fewWT, IL-23p19-/-, IL-22-/- and IL-18-/- mice (namely 10.0%, 11.1%, 8.3% and 18.2%, respec-
tively) at day 8 p.i. (S2A Fig). Whereas no C. jejuni could be cultured from livers of WT and IL-
23p19-/- mice, 16.7% and 18.2% of livers derived from infected IL-22-/- and IL-18-/- mice,
respectively, were pathogen-positive (S2B Fig). Moreover, 30.0%, 22.2%, 16.7% and 9.1% of
WT, IL-23p19-/-, IL-22-/- and IL-18-/- mice, respectively, harbored viable C. jejuni in their kid-
neys (S2C Fig), whereas no pathogenic translocation into cardiac blood could be observed at all
at day 8 p.i. by direct plating (S2D Fig).
We further measured pro-inflammatory cytokines in serum samples taken at day 8 p.i. in
order to survey systemic C. jejuni induced inflammatory responses. Remarkably, despite
absence of viable pathogens in the blood stream, TNF concentrations were elevated in sera of
C. jejuni infected WT (p<0.01), but not in infected mice deficient for IL-23p19, IL-22 or IL-18,
as compared to respective uninfected controls (Fig 8A). Furthermore, TNF, IFN-γ, and IL-6
serum concentrations were lower in IL-18-/- as compared to WT mice at day 8 p.i. (p<0.05; Fig
8). Hence, IL-18 does not only mediate local, but also systemic immune responses in C. jejuni
infected gnotobiotic mice.
Discussion
The IL-23 / IL-22 / IL-18 axis is essentially involved in host defence and in mediating and regu-
lating inflammatory immune responses upon parasitic and bacterial infection [12–15, 23]. In
the present study we shedded further spotlights onto the actors of this orchestrated interplay
between C. jejuni and host immunity and applied the gnotobiotic mice infection model.
Expectedly, the physiological colonization resistance could be completely abrogated in gno-
tobiotic IL-23p19-/-, IL-22-/- and IL-18-/- mice upon depletion of the commensal intestinal
microbiota and subsequently, irrespective of the genotype of mice, stable pathogenic coloniza-
tion of the intestinal tract at comparable and high loads be warranted. In line with our previous
studies [11, 17], infected mice were not clinically compromized and did not exert typical symp-
toms of campylobacteriosis such as wasting or bloody diarrhea. However, IL-18 was essentially
involved in mediating macroscopic sequelae of C. jejuni infection, given that the large intestinal
lengths significantly shortened until day 8 p.i., except for IL-18-/- mice. The better macroscopic
outcome in infected IL-18-/- mice was also true on microscopic level, since infected IL-18-/-
mice displayed less abundant colonic epithelial apoptosis, but, conversely, higher numbers of
proliferating cells counteracting potential infection-induced cell damage as compared to WT
controls. Furthermore, IL-18 mediated adaptive immune and pro-inflammatory responses
upon C. jejuni infection, given that colonic numbers of B lymphocytes and regulatory T cells
were lower in infected IL-18-/- as compared to WT mice. The fact that IL-18 derived from
Whitney U test, and numbers of analyzed animals (in parentheses) are indicated. Data were pooled from four
independent experiments.
doi:10.1371/journal.pone.0158020.g005
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Fig 6. Colonic IL-17A and IL-1βmRNA expression inC. jejuni strain 81–176 infected gnotobiotic mice
lacking IL-23p19, IL-22 or IL-18. (A) IL-17A and (B) IL-1βmRNA levels were determined in colonic ex vivo
biopsies at day (d) 8 (black circles) postinfection by Real Time PCR and expressed in Arbitrary Units (fold
expression). Naive (N) mice served as uninfected controls (white circles). Medians (black bars), level of
significance (p-value) determined by Mann-Whitney U test, and numbers of analyzed animals (in parentheses)
are indicated. Data were pooled from four independent experiments.
doi:10.1371/journal.pone.0158020.g006
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Fig 7. IL-23p19, IL-22, and IL-18 mRNA expression in colonic ex vivo biopsies derived fromC. jejuni
strain 81–176 infected gnotobiotic mice lacking IL-23p19, IL-22 or IL-18. (A) IL-23p19, (B) IL-22, and (C)
IL-18 mRNA levels were determined in colonic ex vivo biopsies at day (d) 8 postinfection (black circles) by
Real Time PCR and expressed in Arbitrary Units (fold expression). Naive (N) mice served as uninfected
controls (white circles). Medians (black bars), level of significance (p-value) determined by Mann-Whitney U
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dendritic cells upon bacterial stimulation directly acts on T cells in order to facilitate conver-
sion to FOXP3+ regulatory T cells [31] might hence explain the less pronounced increase in
FOXP3+ cell numbers within the large intestinal mucosa and lamina propria of C. jejuni
infected IL-18-/- as compared to WT mice.
To date, however, solid data regarding the role of IL-18 in C. jejuni-host interaction, are
scarce. Several in vitro studies demonstrated an upregulated IL-18 gene expression upon C.
jejuni infection [32–34]. Moreover, genes encoding IL-23 and IL-18, but not IL-22, were regu-
lated in differentiated macrophages following C. concisus infection as shown by transcriptomic
and proteomic analyses [35].
Our in vivo data presented here are well in line with our previous murine infection studies
applying a different gram-negative bacterial species, namely Arcobacter butzleri sharing taxo-
nomic relationship with C. jejuni. As for C. jejuni [17], IL-18, but also IL-22 were up-regulated
in the large intestines of A. butzleri infected mice [36, 37]. As shown by us [16, 17] and others
[38], the Th-17 cytokines IL-17A, IL-22 and IFN-γ increased in the intestines of C. jejuni
infected mice. Colonic expression of this cytokine triad, however, was less pronounced in gno-
tobiotic IL-18-/- mice at day 8 p.i. as shown in the present study. Furthemore, C. jejuni induced
large intestinal TNF secretion increased less distinctly in either gene-deficent as compared to
WT mice. Remarkably, eventhough viable pathogens could only sporadically be isolated from
extra-intestinal tissue sites, but not at all from the blood stream, elevated TNF serum levels
could be observed in infected WT, but not IL-18-/- gnotobiotic mice. Hence, IL-18 does not
only mediate local (i.e. intestinal), but also systemic immune responses upon murine C. jejuni
infection.
Our present results are at least in part supported by our very recent investigations applying
a different C. jejuni infection model, namely conventionally colonized infant mice that were
perorally infected immediately after weaning (i.e. by the age of three weeks) [16]. Six days fol-
lowing C. jejuni strain 81–176 infection, colonic numbers of both innate and adaptive immune
cell subsets such as neutrophils, T and B lymphocytes were lower in IL-23p19-/-, IL-22-/- and
IL-18-/- as compared to WT infant mice, whereas large intestinal Treg numbers were lower in
infected IL-23p19-/- and IL-22-/- versus WT infant control animals [39]. In the present study,
however, gnotobiotic IL-22-/- mice exhibited even higher T lymphocyte and Treg numbers in
their colon at day 8 p.i. Remarkably, at day 6 p.i., colonic secretion of pro-inflammatory cyto-
kines including TNF, IFN-γ, IL-6 and MCP-1 was less pronounced in infant IL-18-/- as com-
pared to WT control mice despite stable intestinal colonization of the former only [39].
Furthermore, like in the present study, colonic IL-17A mRNA levels were lower in IL-18-/- as
compared to WT infant mice at day 6 p.i. [40].
Cytokines belonging to the IL-23 / IL-22 / IL-18 axis appear in fact to be differentially
expressed in an orchestrated manner. Upon C. jejuni infection of gnotobiotic mice, colonic IL-
23p19 expression was upregulated in IL-18-/- mice only, whereas IL-22 mRNA levels were
lower in uninfected and infected IL-23p19-/- as well as infected IL-18-/- as compared to respec-
tive wildtype control mice. These results are partly supported by our very recent infection stud-
ies in mice haboring a conventional intestinal microbiota, given that colonic IL-22 mRNA were
down-regulated in infected conventional IL-23p19-/- mice and vice versa (i.e. colonic IL-23p19
mRNA down-regulated in infected conventional IL-22-/- mice) (Heimesaat et al., Gut Patho-
gens, in press). Notably, IL-18 mRNA was downregulated in both, uninfected and C. jejuni
infected conventional IL-22-/- mice, but not the other way round (Heimesaat et al., Gut
test, and numbers of analyzed animals (in parentheses) are indicated. Data were pooled from four
independent experiments.
doi:10.1371/journal.pone.0158020.g007
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Fig 8. Systemic pro-inflammatory cytokine secretion inC. jejuni strain 81–176 infected gnotobiotic
mice lacking IL-23p19, IL-22 or IL-18. (A) TNF, (B) IFN-γ, and (C) IL-6 concentrations were determined in
serum samples taken from gnotobiotic wildtype (WT), IL-23p19-/-, IL-22-/- and IL-18-/- mice at day (d) 8 (black
circles) postinfection. Naive (N) mice served as uninfected controls (white circles). Medians (black bars), level
of significance (p-value) determined by Mann-Whitney U test, and numbers of analyzed animals (in
parentheses) are indicated. Data were pooled from four independent experiments.
doi:10.1371/journal.pone.0158020.g008
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Pathogens, in press). Differences in respective expression patterns might be explained by the
different infection models including absence / presence of the complex commensal intestinal
microbiota given that the interplay between pathogen and host immune system will be essen-
tially influenced by abundance of a complex commensal microbiota.
In conclusion, we here show for the first time that IL-18 is essentially involved in mediating
C. jejuni infection in the gnotobiotic mice model. Further studies should elucidate the underly-
ing regulatory mechanisms orchestrating pathogen-host interactions in more detail.
Supporting Information
S1 Fig. Kinetic survey of fecal blood in perorally infected gnotobiotic mice lacking IL-
23p19, IL-22 or IL-18. Gnotobiotic wildtype (WT), IL-23p19-/-, IL-22-/- and IL-18-/- mice
were generated by broad-spectrum antibiotic treatment and perorally infected with C. jejuni
strain 81–176 by gavage at day 0 and day 1. Abundance of fecal blood was surveyed at (A) day
1, (B) day 5, and (C) day 8 postinfection (p.i.) applying a standardized haemoccult score. Naive
(N) mice served as uninfected controls. Numbers of mice with a fecal blood-positive result out
of the total number of analyzed animals are given in parentheses and means (black bars) are
indicated. Data were pooled from four independent experiments.
(TIFF)
S2 Fig. Extraintestinal translocation of viable intestinal C. jejuni strain 81–176 in perorally
infected gnotobiotic mice lacking IL-23p19, IL-22 or IL-18. Pathogenic translocation to
extraintestinal compartments was assessed by determining C. jejuni strain 81–176 loads (col-
ony forming units (CFU) per gram) in (A) spleen, (B) liver, (C) kidney, and (D) cardiac blood
at day 8 (black circles) postinfection by culture. Numbers of mice harboring the pathogen out
of the total number of analyzed animals are given in parentheses and medians (black bars) are
indicated. Data were pooled from three independent experiments.
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